Medical technology company Smith+Nephew has announced the launch of its ‘TOTAL ANKLE Patient-Matched Guides’.
These guides are designed to offer surgeons a predictable and efficient method for planning and executing total ankle replacement (TAR) procedures.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The all-in-one TOTAL ANKLE Patient-Matched Guides are created to have a precise patient fit utilising fluoroscopic alignment cues and instrumentation and offer accuracy to plan.
The guides are claimed to offer several advantages. Featuring integrated fluoroscopic cues, guide pins, and a cut slot to make the guide a comprehensive instrument, they provide predictability in the operating room.
The guides are also engineered for planning accuracy with their fluoroscopic alignment cues and instrumentation transfer pins.
The guides are also user-friendly offering tactile feedback with a medial arm wrap and ensuring a precise fit for the patient.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSmith+Nephew’s partnership with 3D Systems was integral in designing and manufacturing the TOTAL ANKLE Patient-Matched Guides.
These guides are compatible with chamfer talar implants for Smith+Nephew’s CADENCE Total Ankle System and SALTO TALARIS Total Ankle Prosthesis, providing surgeons with the versatility to choose the best implant for their patients.
Smith+Nephew global trauma and extremities marketing vice-president Mark McMahan said: “We are excited to unveil our new TOTAL ANKLE Patient-Matched Guides for total ankle replacement – a breakthrough to help transform the way healthcare professionals approach surgical precision and improved patient outcomes.
“This advanced system is designed to offer unparalleled efficiency and accuracy, ultimately enhancing the overall experience for both surgeons and patients. The launch of our TOTAL ANKLE Patient-Matched Guides further strengthens our position as a leader in the total ankle replacement market segment.”
In July, the company received 510(k) clearance from the US Food and Drug Administration (FDA) for its CATALYSTEM Primary Hip System.
The system is designed to meet the evolving needs of primary hip surgery, including the expanding role of ambulatory surgery centres and the growing preference for anterior approach procedures.
The CATALYSTEM Primary Hip System has been developed using extensive global data sets across femoral morphologies, to ensure a precision fit.
